QuickView for norpregnadienes (compound)

1. Breast cancer MCF7 cells treated with nuclear receptor agonists
2. Breast cancer T47D cell line treated with progestin R5020
3. Breast cancer T47D cells treated with synthetic progestin, R5020 and/or anti-progestin, telapristone
4. Ductal carcinoma T47D cells with CHD8 siRNA knockdown stimulated with progestin (R5020)
5. Breast cancer T-47D cells PGR-A K388R mutant SUMOylation-deficient treated with progestin R5020

1. Medical treatment with ulipristal acetate for uterine fibroids: Will it be resurrected?
2. Effect of ulipristal acetate on gene expression profile in endometrial cells in culture and in vivo …
3. Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine …
4. A multi-centre, randomized, non-inferiority trial to compare ulipristal with standard surgical treat…
5. Risk-efficacy balance of ulipristal acetate compared to surgical alternatives.

There were no clinical trials for norpregnadienes